Search research articles
Contact Us
Filters
Showing results (1-10 of 180) with videos related to
Page
of 18
Sort By:
Spine
|
December 22, 2000
Outcome assessments in the evaluation of treatment of spinal disorders. Introduction
C Bombardier
Spine
|
December 22, 2000
Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations
C Bombardier
The Journal of Rheumatology
|
May 1, 1979
Some pitfalls of the case-control approach to the investigation of rheumatoid disease
C Bombardier
British Journal of Rheumatology
|
March 1, 1993
The optimal use of cyclosporin A in rheumatoid arthritis: efficacy and outcome measures including quality of life
C Bombardier
The Journal of Rheumatology. Supplement
|
October 1, 1988
Research challenges: overview of epidemiological study designs
C Bombardier
The Journal of Rheumatology
|
April 1, 1985
Looking into the crystal ball: can we estimate the lifetime cost of rheumatoid arthritis?
C Bombardier, J Eisenberg
The Journal of Rheumatology
|
November 11, 1999
Give observational studies a chance: better observational studies make better economic evaluations
A Maetzel, C Bombardier
The Journal of Rheumatology. Supplement
|
November 1, 1983
Methodologic issues in international rheumatologic clinical epidemiology
P Tugwell, C Bombardier
Annals of the Rheumatic Diseases
|
December 1, 1999
Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?
C Bombardier, A Maetzel
The Journal of Rheumatology. Supplement
|
November 1, 1983
Measuring disability: guidelines for rheumatology studies
C Bombardier, P Tugwell
Page
of 18
Search research articles
Search
Showing results (1-10 of 180) with videos related to
Sort By:
Page
of 18
Spine
|
December 22, 2000
Outcome assessments in the evaluation of treatment of spinal disorders. Introduction
C Bombardier
Spine
|
December 22, 2000
Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations
C Bombardier
The Journal of Rheumatology
|
May 1, 1979
Some pitfalls of the case-control approach to the investigation of rheumatoid disease
C Bombardier
British Journal of Rheumatology
|
March 1, 1993
The optimal use of cyclosporin A in rheumatoid arthritis: efficacy and outcome measures including quality of life
C Bombardier
The Journal of Rheumatology. Supplement
|
October 1, 1988
Research challenges: overview of epidemiological study designs
C Bombardier
The Journal of Rheumatology
|
April 1, 1985
Looking into the crystal ball: can we estimate the lifetime cost of rheumatoid arthritis?
C Bombardier, J Eisenberg
The Journal of Rheumatology
|
November 11, 1999
Give observational studies a chance: better observational studies make better economic evaluations
A Maetzel, C Bombardier
The Journal of Rheumatology. Supplement
|
November 1, 1983
Methodologic issues in international rheumatologic clinical epidemiology
P Tugwell, C Bombardier
Annals of the Rheumatic Diseases
|
December 1, 1999
Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?
C Bombardier, A Maetzel
The Journal of Rheumatology. Supplement
|
November 1, 1983
Measuring disability: guidelines for rheumatology studies
C Bombardier, P Tugwell
Page
of 18